Cetilar si conferma medical partner della Federazione Italiana Vela

< 1 MIN

PharmaNutra, with Cetilar, its brand of products designed to reduce the symptoms of post-traumatic joint and muscle pain, will again be medical partner of the Italian Sailing Federation (FIV) for the second consecutive year.

Excellence, innovation and passion are just three defining characteristics common to both the FIV and PharmaNutra that have made this partnership a natural step forward. The pharmaceutical company, founded by the Lacorte brothers, Andrea and Roberto, confirms itself as an active sponsor of sports that best convey brand identity, and will accompany the Italian team with its products and know-how throughout the competition season.

Francesco Ettorre, President of the Italian Sailing Federation (FIV):
“I would like to thank PharmaNutra, who, despite this difficult time for our country, has decided to renew its partnership with our federation. We can continue to count on a company of consolidated values that will accompany our athletes with its support and products throughout this long Olympic campaign”.

Roberto Lacorte, Chairman and CEO of PharmaNutra:
“Partnering with such a prominent organisation as the Italian Sailing Federation and its national teams of prime athletes, who embody our values to perfection is a source of pride and gratification. Sailing is an integral part of PharmaNutra’s DNA and we are certain that once a return has been made to competitive sport, navigating alongside our Italian athletes will bring great satisfaction”.

NOTE: The information provided is for informational purposes only and is not intended to replace the advice of your physician or healthcare professional. The information is intended for healthy individuals, and any dietary regimen or physical activity should be supervised by a competent professional according to Italian law. PharmaNutra SpA assumes no responsibility, as the information is for informational purposes, and anyone interested in undertaking any dietary or physical activity program should consult their specialist.